Deepak Nitrite Subsidiary Deepak Chem Tech Secures ₹48 Cr Internal Funding for Projects
The infusion of ₹48 Crores is a significant internal capital allocation designed to bolster a subsidiary's financial position and fund its projects, suggesting ongoing strategic development within the chemical business.
The internal funding of ₹48 Crores aims to strengthen the capital base and support project expenses for Deepak Chem Tech Limited, indicating investment in growth and expansion within the group.
* Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite Limited, has issued and allotted 48,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS). * Each share has a face value of ₹100, aggregating to a total of ₹48 Crores. * The OCRPS were allotted to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary of the Company. * The objective of this fund infusion is to strengthen DCTL's capital base and support its project expenses and general corporate purposes. * DCTL, operating in the chemical industry, currently runs a state-of-the-art Fluorination plant and is actively pursuing projects across various sites in Gujarat. * DCTL reported a turnover of ₹9.43 Crores for FY 2024-25. The transaction was completed on September 19, 2025, at par and on an "arms length" basis.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.